Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
Cyclin-dependent kinases 12 and 13 (CDK12 and CDK13) play critical roles in the regulation of gene transcription. However, the absence of CDK12 and CDK13 inhibitors has hindered the ability to investigate the consequences of their inhibition in healthy cells and cancer cells. Here we describe the ra...
Main Authors: | Zhang, Tinghu, Kwiatkowski, Nicholas, Olson, Calla M, Dixon-Clarke, Sarah E, Abraham, Brian J, Greifenberg, Ann K, Ficarro, Scott B, Elkins, Jonathan M, Liang, Yanke, Hannett, Nancy M, Manz, Theresa, Hao, Mingfeng, Bartkowiak, Bartlomiej, Greenleaf, Arno L, Marto, Jarrod A, Geyer, Matthias, Bullock, Alex N, Gray, Nathanael S, Young, Richard A. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2017
|
Online Access: | http://hdl.handle.net/1721.1/108541 https://orcid.org/0000-0001-8855-8647 |
Similar Items
-
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
by: Olson, Calla M, et al.
Published: (2018) -
Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors
by: Kalan, Sampada, et al.
Published: (2018) -
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
by: Kwiatkowski, Nicholas P., et al.
Published: (2015) -
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation
by: Krajewska, Malgorzata, et al.
Published: (2021) -
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation
by: Krajewska, Malgorzata, et al.
Published: (2022)